A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Marco Ladetto, Simone Ferrero et al.|Cancers|2021Cited by 13
265 | IMPACT OF IGHV REPERTOIRE AFTER IBRUTINIB‐CONTAINING REGIMENS IN YOUNGER UNTREATED MCL PATIENTS: AN ANALYSIS OF THE TRIANGLE DATA EMBEDDED IN THE MULTIPLY PROJECTSimone Ragaini, Marco Ladetto, Elisa Genuardi et al.|Hematological Oncology|2025Cited by 1